Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) (Exact name of registrant as specified in its charter) Delaware 47-3531161 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 9100 South Hills Blvd, Suite 300 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE ...

© 2023 Sotera Health Company | All Rights Reserved. This presentation refers to, and in other communications with investors the Company may refer to, net sales or revenues or other historical financial information on a "constant currency" basis, which is a non-GAAP financial measure we use to assess performance excluding the impact of foreign currency exchange rate changes. We calculate constant currency net revenues by translating prior year net revenues in local currency at the average exchange rates appl ...

Q3 2022 Earnings Results November 2, 2022 Forward Looking Statements and Non-GAAP Financial Measures Unless expressly indicated or the context requires otherwise, the terms "Sotera Health," "Company," "we," "us," and "our" in this document refer to Sotera Health Company, a Delaware corporation, and, where appropriate, its subsidiaries on a consolidated basis. This presentation contains forward-looking statements that reflect management's expectations about future events and the Company's operating plans and ...

Sotera Health Company (NASDAQ:SHC) Q3 2022 Earnings Conference Call November 2, 2022 9:00 AM ET Company Participants Jason Peterson - Vice President and Treasurer Michael Petras - Chairman and Chief Executive Officer Michael Biehl - Interim Chief Financial Officer Conference Call Participants Sean Dodge - RBC Capital Markets Phil Coover - Goldman Sachs Matt Mishan - KeyBanc Mike Polark - Wolfe Research Operator Good morning. My name is Denise, and I will be your conference call operator today. At this time, ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-39729 SOTERA HEALTH COMPANY (Exact name of registrant as specified in its charter) | Delaware | | 47-35311 ...

Sotera Health Company (NASDAQ:SHC) Q2 2022 Earnings Conference Call August 4, 2022 9:00 AM ET Company Participants Joe Vitale - VP, IR Michael Petras - Chairman and CEO Michael Biehl - Interim CFO Conference Call Participants Lizzie Speyer - Citi Casey Woodring - JPMorgan Michael Polark - Wolfe Research Matthew Mishan - KeyBanc Ben Flox - Jefferies Luke Sergott - Barclays Thomas Kelliher - RBC Capital Markets Operator Good morning. My name is Howard and I will be your conference call operator today. At this ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-39729 SOTERA HEALTH COMPANY (Exact name of registrant as specified in its charter) | Delaware | | 47-3531161 | ...

Q2 2022 Earnings Results August 4, 2022 Forward Looking Statements and Non-GAAP Financial Measures Unless expressly indicated or the context requires otherwise, the terms "Sotera Health," "Company," "we," "us," and "our" in this document refer to Sotera Health Company, a Delaware corporation, and, where appropriate, its subsidiaries on a consolidated basis. This presentation contains forward-looking statements that reflect management's expectations about future events and the Company's operating plans and p ...

Sotera Health Company (NASDAQ:SHC) Q1 2022 Results Conference Call May 5, 2022 9:00 AM ET Company Participants Michael Petras - Chairman and CEO Scott Leffler - CFO Conference Call Participants Sean Dodge - RBC Capital Luke Sergott - Barclays Matt Miksic - Credit Suisse Patrick Donnelly - Citi Matthew Mishan - KeyBanc Dave Windley - Jefferies Michael Polark - Wolfe Research Casey Woodring - JPMorgan Operator Good morning. This is Joe and welcome to Sotera Health's First Quarter 2022 Results Call. You may fi ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-39729 SOTERA HEALTH COMPANY (Exact name of registrant as specified in its charter) | Delaware | | 47-3531161 | ...